ABOUT THE PACKARD CENTER

Packard Center for ALS Research at Johns Hopkins

The Packard Center for ALS Research at Johns Hopkins enables the world’s best ALS scientists to collaborate and access funding so that they may continue work to rapidly develop new treatments and find a cure for ALS, also known as Lou Gehrig’s disease. The hope is in the science. Get Involved. >>

ALS Headlines

ALS Headlines from the Packard Center
  1. 3-D Hand Movement Reconstructed Using Brain Signals

    Researchers have successfully reconstructed 3-D hand motions from brain signals recorded in a non-invasive way. This finding uses a technique that may open new doors for portable brain-computer interface systems.
    Tue, 09 Mar 2010 03:43:22 GMThttp://www.alscenter.org/news/rss_als_headlines/10_03_08.html
  2. Induced Neural Stem Cells: Not Quite Ready for Prime Time

    The great promise of induced pluripotent stem cells is that the all-purpose cells seem capable of performing all the same tricks as embryonic stem cells, but without the controversy.
    Thu, 18 Feb 2010 19:24:16 GMThttp://www.alscenter.org/news/rss_als_headlines/10_02_16
  3. New Class of Brain-Protecting Drugs Emerging

    Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease.
    Tue, 02 Feb 2010 18:03:25 GMThttp://www.alscenter.org/news/rss_als_headlines/10_02_02.html
  4. First U.S. stem cells transplanted into spinal cord

    Doctors injected stem cells from 8-week-old fetal tissue into the spine of a man in his early 60s who has advanced ALS, or amyotrophic lateral sclerosis.
    Fri, 22 Jan 2010 20:37:47 GMThttp://www.alscenter.org/news/rss_als_headlines/10_01_21_cnn.html

From The Center

News from the Robert Packard Center for ALS Research at Johns Hopkins
  1. License Agreement to Develop New Treatments for Neurological Disease

    Newly formed NeuroTranslational Program at JHU has entered into a licensing agreement with pharmaceutical company Eisai Inc. to discover and develop small molecule glutamate carboxypeptidase II (GCPII) inhibitors.
    Mon, 15 Mar 2010 17:38:45 GMThttp://www.alscenter.org/news/rss_from_the_packard_center/10_03_15.html
  2. NIH Grant Funds Study on Stem Cells from ALS Patients

    A two-year $3.7 million stimulus grant from the National Institutes of Health will allow Johns Hopkins neurologist Jeffrey Rothstein to expand on his research into the nerve- and muscle-wasting disease amyotrophic lateral sclerosis, or ALS.
    Tue, 23 Feb 2010 18:32:33 GMThttp://www.alscenter.org/news/rss_from_the_packard_center/10_02_22.html
  3. Project A.L.S. and Packard Center Take Aim at ALS with $15 Million Program

    Project A.L.S. and the Robert Packard Center for ALS Research at Johns Hopkins will partner on P2 ALS, a $15 million initiative designed to advance ALS research exponentially over the next three years.
    Fri, 29 Jan 2010 15:03:47 GMThttp://www.alscenter.org/news/research_news_archive/10/10_01_29.html

Stay Connected

Sign up for e-mail updates by submitting your email address here.

The Numbers

  • 50

    % OF NEW ALS DRUGS IN THE PIPELINE DEVELOPED BY PACKARD CENTER

  • 90

    EVERY 90 MINUTES A PERSON IN THE U.S. IS DIAGNOSED

  • 125

    ELITE SCIENTISTS WORKING ON ALS RESEARCH EVERY DAY

Johns Hopkins School of Medicine

Contact The Packard Center

© 2010, The Robert Packard Center for ALS Research at Johns Hopkins. All rights reserved.

5801 Smith Avenue, McAuley Suite 110,
Baltimore, Maryland 21209, USA